Allianz Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,205	Closed	-$183K	–	2586
2021 Q3	$183K	Sell	15,205 -4,500	-23%	-$65.5K	﹤0.01%	2504
2021 Q2	$417K	Sell	19,705 -14,640	-43%	-$353K	﹤0.01%	2127
2021 Q1	$963K	Hold	34,345	–	–	﹤0.01%	1657
2020 Q4	$893K	Sell	34,345 -25,080	-42%	-$751K	﹤0.01%	1511
2020 Q3	$2.21M	Sell	59,425 -1,326	-2%	-$52.5K	﹤0.01%	1231
2020 Q2	$3.12M	Buy	60,751 +15,347	+34%	+$642K	﹤0.01%	1418
2020 Q1	$1.43M	Buy	45,404 +5,482	+14%	+$289K	﹤0.01%	1647
2019 Q4	$2.38M	Buy	+39,922	New	+$1.79M	﹤0.01%	1790
2019 Q2	–	Sell	-31,078	Closed	-$1.25M	–	2701
2019 Q1	$1.25M	Sell	31,078 -12,389	-29%	-$556K	﹤0.01%	2020
2018 Q4	$1.97M	Sell	43,467 -23,638	-35%	-$1.14M	﹤0.01%	1772
2018 Q3	$2.98M	Hold	67,105	–	–	﹤0.01%	1794
2018 Q2	$2.63M	Buy	67,105 +44,654	+199%	+$2.26M	﹤0.01%	1822
2018 Q1	$1.62M	Buy	+22,451	New	+$1.65M	﹤0.01%	2020
2015 Q4	–	Sell	-102,020	Closed	-$2.41M	–	2463
2015 Q3	$2.41M	Buy	102,020 +36,480	+56%	+$2.29M	﹤0.01%	1532
2015 Q2	$5.36M	Buy	65,540 +373	+0.6%	+$36.5K	0.01%	1358
2015 Q1	$6.03M	Buy	65,167 +30,600	+89%	+$1.97M	0.01%	1148
2014 Q4	$1.4M	Buy	+34,567	New	+$1.06M	﹤0.01%	1701

Other funds holding ESPR